Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Egan

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
European Journal of Pharmacology|June 25, 1991
Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in rat prefrontal cortex, nucleus accumbens and striatumM F Egan, F Karoum, R J Wyatt
Brain Research Bulletin|January 1, 1995
Effects of chronic naloxone administration on vacuous chewing movements and catalepsy in rats treated with long-term haloperidol decanoateM F Egan, J N Ferguson, T M Hyde
Schizophrenia Research|December 20, 2000
Effects of smoking during antipsychotic withdrawal in patients with chronic schizophreniaJ A Apud, M F Egan, R J Wyatt
European Journal of Pharmacology|November 3, 1992
gamma-Butyrolactone-sensitive and -insensitive dopamine release, and their relationship to dopamine metabolism in three rat brain regionsS J Chrapusta, F Karoum, M F Egan, et al.
European Journal of Pharmacology|March 16, 1993
Haloperidol and clozapine increase intraneuronal dopamine metabolism, but not gamma-butyrolactone-resistant dopamine releaseS J Chrapusta, F Karoum, M F Egan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 1996
The effects of acute and chronic haloperidol treatment on dopamine release mediated by the medial forebrain bundle in the striatum and nucleus accumbensM F Egan, S J Chrapusta, F Karoum, et al.
Journal of Neurochemistry|October 1, 1993
Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic studyF Karoum, S J Chrapusta, M F Egan, et al.
Synapse (New York, N.Y.)|November 9, 2000
Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatmentN M Dawson, E H Hamid, M F Egan, et al.
Synapse (New York, N.Y.)|June 1, 1995
Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidolB K Lipska, S J Chrapusta, M F Egan, et al.
Psychopharmacology|January 1, 1995
Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol doseM F Egan, T M Hyde, J E Kleinman, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|June 25, 1991
Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in rat prefrontal cortex, nucleus accumbens and striatumM F Egan, F Karoum, R J Wyatt
Brain Research Bulletin|January 1, 1995
Effects of chronic naloxone administration on vacuous chewing movements and catalepsy in rats treated with long-term haloperidol decanoateM F Egan, J N Ferguson, T M Hyde
Schizophrenia Research|December 20, 2000
Effects of smoking during antipsychotic withdrawal in patients with chronic schizophreniaJ A Apud, M F Egan, R J Wyatt
European Journal of Pharmacology|November 3, 1992
gamma-Butyrolactone-sensitive and -insensitive dopamine release, and their relationship to dopamine metabolism in three rat brain regionsS J Chrapusta, F Karoum, M F Egan, et al.
European Journal of Pharmacology|March 16, 1993
Haloperidol and clozapine increase intraneuronal dopamine metabolism, but not gamma-butyrolactone-resistant dopamine releaseS J Chrapusta, F Karoum, M F Egan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 1996
The effects of acute and chronic haloperidol treatment on dopamine release mediated by the medial forebrain bundle in the striatum and nucleus accumbensM F Egan, S J Chrapusta, F Karoum, et al.
Journal of Neurochemistry|October 1, 1993
Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic studyF Karoum, S J Chrapusta, M F Egan, et al.
Synapse (New York, N.Y.)|November 9, 2000
Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatmentN M Dawson, E H Hamid, M F Egan, et al.
Synapse (New York, N.Y.)|June 1, 1995
Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidolB K Lipska, S J Chrapusta, M F Egan, et al.
Psychopharmacology|January 1, 1995
Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol doseM F Egan, T M Hyde, J E Kleinman, et al.
Pageof 7